Publications

Title

Author

Year

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?.

Nelson, KN; Churchyard, G; Cobelens, F; Hanekom, WA; Hill, PC; Lopman, B; Mave, V; Rangaka, MX; Vekemans, J; WHITE, RG; Wong, EB; Martinez, L; García-Basteiro, AL;

2023

The Lancet. Microbe, (2023).4 8 10.1016/s2666-5247(23)00112-x.

Data for: "Impact of micro- and macronutrient status on the incidence of tuberculosis: an examination of an African cohort initiating antiretroviral therapy".

SCHWALB, A;

2023

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2023). 10.17037/DATA.00003506.

Asymptomatic but infectious - The silent driver of pathogen transmission. A pragmatic review.

SHAIKH, N; Swali, P; HOUBEN, RM G J;

2023

Epidemics, (2023).44, 10.1016/j.epidem.2023.100704.

Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis.

Dhana, A; Gupta, RK; Hamada, Y; Kengne, AP; Kerkhoff, AD; Yoon, C; Cattamanchi, A; Reeve, BW P; Theron, G; Ndlangalavu, G; Wood, R; Drain, PK; CALDERWOOD, CJ; Noursadeghi, M; Boyles, T; Meintjes, G; Maartens, G; Barr, DA;

2023

European respiratory review : an official journal of the European Respiratory Society, (2023).32 168 10.1183/16000617.0021-2023.

Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.

Rehal, S; Cro, S; Phillips, PP; FIELDING, K; CARPENTER, JR;

2023

Clinical trials (London, England), (2023).20 5 10.1177/17407745231176773.

Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data.

Broger, T; Koeppel, L; Huerga, H; Miller, P; Gupta-Wright, A; Blanc, F-X; Esmail, A; Reeve, BW P; Floridia, M; Kerkhoff, AD; Ciccacci, F; Kasaro, MP; Thit, SS; Bastard, M; Ferlazzo, G; Yoon, C; Van Hoving, DJ; Sossen, B; García, JI; Cummings, MJ; Wake, RM; Hanson, J; Cattamanchi, A; Meintjes, G; Maartens, G; ... TBYield Study Consortium,

2023

The Lancet Global health, (2023).11 6 10.1016/S2214-109X(23)00135-3.

Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.

Trevisi, L; Hernán, MA; Mitnick, CD; Khan, U; Seung, KJ; Rich, ML; Bastard, M; Huerga, H; Melikyan, N; Atwood, SA; Avaliani, Z; Llanos, F; Manzur-Ul-Alam, M; Zarli, K; Binegdie, AB; Adnan, S; Melikyan, A; Gelin, A; Isani, AK; Vetushko, D; Daugarina, Z; Nkundanyirazo, P; Putri, FA; Vilbrun, C; Khan, M; ... Franke, MF.

2023

American journal of respiratory and critical care medicine, (2023).207 11 10.1164/rccm.202211-2125oc.

Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?.

D Freire, I; L Fielding, K; A J Moore, D;

2023

PloS one, (2023).18 5 10.1371/journal.pone.0286306.

Data supporting "Prevalence of subclinical pulmonary tuberculosis and its association with HIV in household contacts of tuberculosis in two South African provinces: analysis of a cluster-randomised trial".

Carter, N; WEBB, E; Lebina, L; Motsomi, K; Bosch, Z; Martinson, N; MacPherson, P;

2023

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2023). 10.17037/DATA.00003373.

Is neglect of self-clearance biassing TB vaccine impact estimates?.

SCARPONI, D; Clark, R; Weerasuriya, C; EMERY, J; Houben, RM G J; WHITE, R; MCCREESH, N;

2023

medRxiv (2023). 10.1101/2023.04.11.23288400.